NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $296,401 | -64.3% | 18,353 | -8.4% | 0.00% | -75.0% |
Q2 2023 | $831,328 | -30.8% | 20,032 | +0.2% | 0.00% | -33.3% |
Q1 2023 | $1,201,778 | +0.2% | 19,983 | +22.2% | 0.01% | 0.0% |
Q4 2022 | $1,199,713 | -3.5% | 16,356 | -0.1% | 0.01% | -14.3% |
Q3 2022 | $1,243,000 | -69.9% | 16,366 | -72.5% | 0.01% | -70.8% |
Q2 2022 | $4,130,000 | -35.1% | 59,419 | -22.7% | 0.02% | -22.6% |
Q1 2022 | $6,368,000 | +148.8% | 76,867 | +125.4% | 0.03% | +158.3% |
Q4 2021 | $2,560,000 | -27.8% | 34,097 | +11.8% | 0.01% | -36.8% |
Q3 2021 | $3,544,000 | -36.7% | 30,505 | +20.8% | 0.02% | -38.7% |
Q2 2021 | $5,602,000 | +110.8% | 25,256 | +25.6% | 0.03% | +93.8% |
Q1 2021 | $2,658,000 | +6.7% | 20,110 | +39.7% | 0.02% | +6.7% |
Q4 2020 | $2,491,000 | +123.4% | 14,396 | +43.7% | 0.02% | +87.5% |
Q3 2020 | $1,115,000 | +99.1% | 10,016 | +6.1% | 0.01% | +60.0% |
Q2 2020 | $560,000 | +28.7% | 9,442 | +46.1% | 0.01% | +25.0% |
Q1 2020 | $435,000 | -2.5% | 6,462 | +22.2% | 0.00% | +33.3% |
Q4 2019 | $446,000 | +23.9% | 5,287 | +9.8% | 0.00% | 0.0% |
Q3 2019 | $360,000 | +24.6% | 4,813 | +5.2% | 0.00% | +50.0% |
Q2 2019 | $289,000 | +49.0% | 4,573 | +13.6% | 0.00% | 0.0% |
Q1 2019 | $194,000 | +50.4% | 4,027 | +4.9% | 0.00% | +100.0% |
Q4 2018 | $129,000 | -35.8% | 3,839 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $201,000 | +67.5% | 3,839 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $120,000 | +96.7% | 3,839 | +37.2% | 0.00% | 0.0% |
Q1 2018 | $61,000 | +7.0% | 2,799 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $57,000 | +280.0% | 2,799 | +276.2% | 0.00% | – |
Q3 2017 | $15,000 | – | 744 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |